Renalytix Plc
Status: Publicly traded
Direct answer
Renalytix Plc is publicly traded on LSE under the ticker RENX.L.
Renalytix Plc specializes in developing cutting-edge in vitro diagnostic solutions for kidney diseases, leveraging the power of artificial intelligence. Their primary offering, KidneyIntelX, is an advanced diagnostic platform. It employs a sophisticated AI-enabled algorithm that synthesizes various data streams, such as scientifically validated blood biomarkers, inherited genetic factors, and personalized patient...
Can you invest in Renalytix Plc?
Yes. Renalytix Plc trades publicly on LSE as RENX.L.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Renalytix Plc
Detailed equity research is provided by MarketSnap.